Aurolife Fexofenadine 180mg Tablets Recall: Impurities May Cause Harm
Aurolife Pharma recalls 180mg fexofenadine tablets with specific lot numbers due to failed impurities and degradation specifications. Consumers should check their packaging for NDC codes and lot numbers to determine if affected.
Recall notice
Failed Impurities/Degradation Specifications
Contact the company
What happened, in plain English
Aurolife Pharma is recalling 180mg fexofenadine hydrochloride tablets that may contain impurities or degrade improperly. This could pose a health risk, so affected consumers should stop using the product and contact the manufacturer for details. Read more at govinfonow.com/recall/38072-aurolife-fexofenadine-180mg-tablets-recall-impurities-may-cause-harm.
Source Summary by GovInfoNow · govinfonow.com/recall/38072-aurolife-fexofenadine-180mg-tablets-recall-impurities-may-cause-harm · Updated October 5, 2026 · FDA enforcement record: FDA #D-1870-2019
Cite this page
“Aurolife Fexofenadine 180mg Tablets Recall: Impurities May Cause Harm.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/38072-aurolife-fexofenadine-180mg-tablets-recall-impurities-may-cause-harm. Based on FDA recall #D-1870-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1870-2019%22&limit=1).
Why it’s dangerous
The tablets failed impurities and degradation specifications, meaning they may contain harmful substances or break down in a way that could affect safety. This could lead to health issues if the product is consumed.
Who’s affected
People who purchased the 15-count or 30-count cartons of fexofenadine tablets from HealthMart Pharmacy with the listed lot numbers are affected. Those taking allergy medication regularly are at higher risk.
How to tell if you have this one
Check for 15-count or 30-count cartons with NDC codes 62011-0315-1 or 62011-0315-2. Look for lot numbers 067180010B (expiring 03/21), 067180024E1 (expiring 07/21), or 067180016A (expiring 05/21).
- Brand
Aurolife- Category
Drug
All 11 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class II- Status
Terminated- Distribution
Nationwide in the USA
| Recall number | Product, codes & lots | Quantity |
|---|---|---|
| D-1864-2019 | Fexofenadine Hydrochrloride Tablets USP, 180 mg, 100-count bottle, Distributed by: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648, NDC 58602-711-21; Lot #: 067180008A, Exp 03/21 | 8,240 bottles |
| D-1865-2019 | Allergy Relief (Fexofenadine Hydrochrloride) Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 60000-409-53); b) 30-count cartons (NDC 60000-409-30); c) 45-count bonus cartons (NDC 60000-409-48); d) 45-count cartons (NDC 60000-409-45); CAREone, Distributed by: Foodhold U.S.A., LLC, Landover, MD 20785.; Lot #s: a) 067180025D1, Exp 07/21; b) 067180025B1, Exp 07/21; c) 067180025A1, Exp 07/21; d) 067180025C1, Exp 07/21 | a) 9662 cartons; b) 7382 cartons; c) 5184 cartons; d) 9842 cartons |
| D-1866-2019 | Allergy Relief (fexofenadine hydrochrloride) tablets, 180 mg, 5-count carton, Good Neighbor Pharmacy, Distributed By Amerisource Bergen, 1300 Morris Drive, Chesterbrook, PA 19087, NDC 46122-387-23.; Lot #: 067180024A1, Exp 07/21 | 3240 cartons |
| D-1867-2019 | fexofenadine hydrochloride tablets USP, 180 mg, 150-count bottle, Member's Mark, Distributed by: Sam's West, Inc., Bentonville, AR 22716, NDC 68196-976-91, UPC 0 78742 23550 9.; Lot #'s: 067180009A, Exp 03/21; 067180013A, 067180014A, 067180015A, Exp 04/21; 067180018A, Exp 05/21; 067180020A, Exp 06/21; 067180021A1, 067180022A1, Exp 07/21; 06718028A1, 06718028B1, Exp 09/21; 06719001A3, Exp 01/22 | 71,748 bottles |
| D-1868-2019 | Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 30-count carton (NDC 70677-0008-2) and b) 15-count carton (NDC 70677-0008-1), sunmark, Distributed by McKesson, One Post Street, San Francisco, CA 94104.; Lot #s: a) 067180016B, Exp 05/21 and b) 067180024F1, Exp 07/21 | a) 11,928 cartons; b) 288 cartons |
| D-1869-2019 | Allergy Relief (Fexofenadine HCl) tablets USP, 180 mg, 15-count cartons, equate, Distributed by: Wal-Mart Stores, Inc., Bentonville, AR 72716, NDC 49035-995-62.; Lot #s: 067180010A, Exp 03/21; 067180023C1, 067180024D1, Exp 07/21 | 129,600 cartons |
| D-1870-2019 | Fexofenadine Hydrochloride Tablets USP, 180 mg, packaged in a) 15-count cartons (NDC 62011-0315-1); and b) 30-count cartons (NDC 62011-0315-2) HealthMart PHARMACY, Distributed by McKesson, One Post Street, San Francisco, CA 94104.; Lot #s: a) 067180010B, Exp 03/21; 067180024E1, Exp 07/21; b) 067180016A, Exp 05/21 | a) 10,992 cartons; b) 24,792 cartons |
| D-1871-2019 | Fexofenadine HCL Tablets USP, 180 mg, 500's BRITE STOCK; Manufactured for: Aurohealth LLC., 2572 Brunswick Pike, Lawrenceville, NJ 08648; Manufactured by: Aurolife Pharma LLC, Dayton, NJ 08810.; Lot #s:067180011A, 067180012A, Exp 04/21, 06718027B1, Exp 09/21 | 6104 bottles |
| D-1872-2019 | Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count bottles, Distributed by: Aurohealth LLC, 2572 Brunswick Pike, Lawrenceville, NJ 08648; NDC 58602-820-09.; Lot #: 067180026A1, Exp 07/21 | 240 bottles |
| D-1873-2019 | Wal-Fex (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 5-count cartons, Distributed By: Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-0097-55.; Lot #: 06718027A1, Exp 09/21 | 4920 cartons |
| D-1874-2019 | Allergy (Fexofenadine Hydrochloride) Tablets USP, 180 mg, 30-count cartons, DISCOUNT drug mart FOOD FAIR, Distributed by: Discount Drug Mart, 211 Commerce Drive, Medina, OH 44256, NDC 53943-021-09.; Lot #: 067180024B1, Exp 07/21 | 4536 cartons |
What to do — step by step
Check Product Packaging
Look for the NDC codes 62011-0315-1 or 62011-0315-2 and lot numbers listed above to confirm if your tablets are affected.
Where it went and when
Where it was distributed
Distributed nationwide.
FDA distribution: “Nationwide in the USA” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide.
Recall timeline
FDA terminated this recall 3 years after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1870-2019 (August 23, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1870-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.